证券代码：300796 证券简称：贝斯美 公告编号：2025-070 绍兴贝斯美化工股份有限公司 关于非独立董事兼副总经理辞职暨选举职工代表董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 一、关于非独立董事辞职及选举职工代表董事的情况 绍兴贝斯美化工股份有限公司（以下简称"公司"）于近日收到非独立董 事兼副总经理任纪纲先生递交的书面辞职报告。因工作调整，任纪纲先生辞去公 司第四届董事会非独立董事和副总经理的职务（任纪纲先生原定担任第四届董 事会非独立董事和副总经理的任期为2024年12月27日至2027年12月27日），辞 任后将继续在公司担任总工程师。 为保障公司董事会构成符合《中华人民共和国公司法》及《公司章程》的相关 规定，公司于2025年9月3日召开2025年第一次职工代表大会，审议通过了《关于 选举第四届董事会职工代表董事的议案》。经职工代表大会民主选举，选举任 纪纲先生（简历详见附件）担任公司第四届董事会职工代表董事，任期自公司 职工代表大会选举之日起至第四届董事会任期届满之日止。 任纪纲先生符合《公司法》《公司章程》规定的有关职工代表 ...

证券代码：300796 证券简称：贝斯美 公告编号：2025-068 绍兴贝斯美化工股份有限公司 2025年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开情况 1、 会议召开时间： （1） 现场会议时间：2025年8月28日（星期四）下午14:00开始。 （2） 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025年8月28日9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所 互联网投票系统（http://wltp.cninfo.com.cn）投票的具体时间为:2025年8月28 日09:15-15:00期间的任意时间。 2、 现场会议召开地点：浙江省绍兴市上虞区杭州湾经济技术开发区经十一路2号公 司2楼会议室 3、 会议召开方式：以现场表决、网络投票相结合的方式 4、 会议召集人：董事会 特别提示 1、本次股东大会无增加、变更、否决议案的情况； 5、 主持人：董事长钟锡君先生 6、 本次会议的召集、召开与表 ...

北京金诚同达律师事务所 关于 绍兴贝斯美化工股份有限公司 2025 年第二次临时股东大会的 法律意见书 北京市朝阳区建国门外大街 1 号国贸大厦 A 座 10 层 电话：010-5706 8585 传真：010-6518 5057 金诚同达律师事务所 法律意见书 北京金诚同达律师事务所 关于绍兴贝斯美化工股份有限公司 本所律师声明： 1. 本所律师仅就本次股东大会的召集、召开程序，出席会议人员的资格、 召集人资格，会议的表决程序、表决结果的合法性发表意见，不对本次股东大会 所审议的议案内容及该等议案所表述的事实或数据的真实性、准确性和完整性发 表意见； 2. 本所律师已经按照《股东会规则》的要求，对本次股东大会所涉及的相 关事项进行了核查和验证，所发表的结论性意见合法、准确，不存在虚假记载、 误导性陈述或者重大遗漏，并承担相应法律责任； 1 2025 年第二次临时股东大会的 法律意见书 金证法意[2025]字 0828 第 0763 号 致：绍兴贝斯美化工股份有限公司 北京金诚同达律师事务所（以下简称"本所"）接受绍兴贝斯美化工股份有 限公司（以下简称"贝斯美"或"公司"）的聘请，指派本所律师出席公司 202 ...

Core Viewpoint - The stock of Beishimei experienced a decline of 2.02% on August 27, with a trading price of 11.17 yuan per share and a total market capitalization of 4.034 billion yuan, indicating a mixed performance in recent trading sessions [1]. Financial Performance - For the first half of 2025, Beishimei achieved operating revenue of 776 million yuan, representing a year-on-year growth of 16.57%. The net profit attributable to shareholders was 34.706 million yuan, showing a significant increase of 109.70% compared to the previous period [2]. - Since its A-share listing, Beishimei has distributed a total of 62.87 million yuan in dividends, with 38.52 million yuan distributed over the past three years [3]. Stock Market Activity - As of August 27, Beishimei's stock price has increased by 9.40% year-to-date, but it has seen a decline of 6.92% over the last five trading days. In the last 20 days, the stock rose by 3.71%, and in the last 60 days, it increased by 3.81% [1]. - The stock's trading volume on August 27 was 131 million yuan, with a turnover rate of 3.20%. The net outflow of main funds was 16.33 million yuan, with significant selling pressure observed [1]. Company Overview - Beishimei, established on March 31, 2003, and listed on November 15, 2019, is located in Shaoxing, Zhejiang Province. The company specializes in the research, production, and sales of various chemical products, primarily focusing on 4-nitro intermediates, dimethenamid-p active ingredients, and formulations [1]. - The revenue composition of Beishimei includes 25.95% from dimethenamid-p active ingredients, 25.54% from trade herbicides, 18.91% from trade insecticides, and other chemical products [1]. Shareholder Information - As of June 30, Beishimei had 19,900 shareholders, an increase of 82.96% from the previous period. The average number of tradable shares per shareholder decreased by 45.34% to 18,160 shares [2].

Group 1 - The company Beishimei (300796) will disclose detailed operating data for the first half of 2025 on August 20, 2025 [1]

Core Viewpoint - Beishimei (300796) confirmed on August 25 that it does not trigger ST risk warning according to the Shenzhen Stock Exchange's GEM listing rules [1] Group 1 - The company addressed investor inquiries on its interactive platform [1] - The company reassured stakeholders regarding its compliance with listing regulations [1]

Core Viewpoint - The company, Bestme (300796), will disclose shareholder information in its periodic reports according to the principle of fairness in information disclosure [1] Group 1 - The company will provide shareholder information for specific reporting periods [1] - For inquiries regarding shareholder numbers at other times, shareholders must provide written proof of their shareholdings and quantities [1] - The company will verify shareholder identities before providing the requested information [1]

Core Viewpoint - The stock price of Beishimei is reported at 11.50 yuan as of August 22, 2025, reflecting a decrease of 0.06 yuan or 0.52% from the previous trading day [1] Group 1: Company Overview - Beishimei's main business includes the research, production, and sales of pesticide raw materials and formulations, with additional involvement in the new materials sector [1] - The company operates in various segments, including pesticides and veterinary drugs, Zhejiang sector, and ChiNext Composite Index [1] Group 2: Technological Advancements - The company has claimed expertise in several new material technologies, including "isoprene raw material pretreatment technology" and "isoprene selective hydrogenation technology," which are expected to support future development in high-end carbon five new materials [1] Group 3: Financial Performance - On August 22, 2025, the main capital outflow for Beishimei was 16.54 million yuan, with a cumulative net outflow of 116 million yuan over the past five days [1] - The trading volume on the same day was 185 million yuan, with a turnover rate of 4.45%, and the total market capitalization stood at 4.153 billion yuan [1]

Core Viewpoint - The company, Beishimei, reported strong financial performance in the first half of 2025, driven by its robust market competitiveness in the environmentally friendly pesticide sector and strategic expansion into new materials [1][2]. Financial Performance - In the first half of 2025, Beishimei achieved revenue of 776 million yuan, a year-on-year increase of 16.57% [1] - The net profit attributable to shareholders reached 34.71 million yuan, up 109.70% year-on-year [1] - The basic earnings per share were 0.1 yuan, reflecting a 100.00% increase compared to the previous year [1] Industry Trends - The Chinese pesticide market is projected to reach 450 billion yuan in 2024 and exceed 480 billion yuan in 2025, with a compound annual growth rate (CAGR) of 6.5% [2] - The demand for efficient, safe, and environmentally friendly pesticide products is increasing, driven by agricultural modernization and green development initiatives [2] Product and Technology Development - Beishimei has established a complete industrial chain for its self-produced pesticides, covering intermediates, active ingredients, and formulations [2] - The company holds 62 authorized patents, including 33 invention patents, emphasizing its commitment to technological innovation [4] - The purity of its active ingredient, dimethenamid-P, exceeds 98%, surpassing domestic industry standards [4] Strategic Initiatives - Beishimei is implementing a strong chain and supplement strategy, focusing on the production of key intermediates and raw materials to ensure quality and cost control [3] - The company has launched a project to produce 8,500 tons of ketone series green materials, enhancing its position in the carbon five materials sector [8] International Expansion - Beishimei's subsidiary, Ningbo Jielike, has established a sales network in 79 countries, significantly contributing to the company's overseas revenue, which reached 571 million yuan in the first half of 2025 [6] - The company’s export volume of herbicides increased by 11.11% year-on-year, indicating strong growth in international markets [5] New Materials Strategy - The carbon five series products generated revenue of 61.24 million yuan, a year-on-year increase of 141.83%, highlighting the growth potential in this segment [7] - Beishimei is focusing on the development of high-end carbon five products to capture the import substitution opportunities in the market [7][8]

Core Viewpoint - Beishimei (300796) reported strong financial performance for the first half of 2025, with significant increases in revenue and net profit compared to the previous year [1] Financial Performance Summary - Total revenue for the first half of 2025 reached 776 million yuan, a year-on-year increase of 16.57% [1] - Net profit attributable to shareholders was 34.71 million yuan, up 109.7% year-on-year [1] - In Q2 2025, total revenue was 354 million yuan, reflecting a 13.4% increase year-on-year, while net profit for the quarter was 8.72 million yuan, soaring 344.08% year-on-year [1] - Gross margin improved to 18.72%, an increase of 3.3% year-on-year, and net margin rose to 4.42%, up 82.92% year-on-year [1] - Total expenses (selling, administrative, and financial) amounted to 83.89 million yuan, accounting for 10.81% of revenue, a decrease of 6.97% year-on-year [1] Key Financial Metrics - Earnings per share (EPS) doubled to 0.1 yuan, a 100% increase year-on-year [1] - Net asset value per share increased to 4.78 yuan, up 4.28% year-on-year [1] - Operating cash flow per share was -0.06 yuan, a significant decrease of 162.44% year-on-year [1] Changes in Financial Items - Sales expenses increased by 31.42% due to higher salaries for sales personnel and marketing expenses [2] - Financial expenses decreased by 49.8% due to reduced losses [2] - Income tax expenses rose by 45.25%, primarily due to profits from tax-exempt regions and a decrease in deferred tax expenses [2] - Net cash flow from operating activities decreased by 162.44% due to increased cash payments for goods and services [2] - Net cash flow from investing activities increased by 77.29% due to reduced capital expenditures [2] - Net cash flow from financing activities decreased by 61.27% due to increased cash payments for debt repayment [2] Business Model and Investment Considerations - The company's performance is heavily reliant on capital expenditures, necessitating careful evaluation of the profitability of these investments [3] - Historical financial performance indicates a median Return on Invested Capital (ROIC) of 10.08%, with a notably poor ROIC of -0.9% in 2024 [3] - Analysts suggest monitoring the company's cash flow situation, debt levels, and accounts receivable status [4]